A
ABL Bio Inc
KOSDAQ:298380
ABL Bio Inc
KOSDAQ:298380
Price:
184 400
KRW
-2.54%
Market Cap:
₩10.2T
Balance Sheet
Balance Sheet Decomposition
ABL Bio Inc
ABL Bio Inc
Balance Sheet Decomposition is not available for
ABL Bio Inc
ABL Bio Inc
Balance Sheet
ABL Bio Inc
ABL Bio Inc
Currency: KRW
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
5 340
|
1 996
|
122 035
|
91 146
|
40 658
|
21 589
|
25 136
|
28 064
|
56 289
|
|
| Cash Equivalents |
5 340
|
1 996
|
122 035
|
91 146
|
40 658
|
21 589
|
25 136
|
28 064
|
56 289
|
|
| Short-Term Investments |
0
|
7 174
|
32 865
|
42 141
|
29 733
|
22 058
|
53 174
|
43 085
|
84 371
|
|
| Total Receivables |
77
|
10
|
5 745
|
755
|
1 394
|
208
|
573
|
2 003
|
1 223
|
|
| Accounts Receivables |
0
|
0
|
5 386
|
9
|
865
|
3
|
4
|
51
|
617
|
|
| Other Receivables |
0
|
0
|
359
|
746
|
2 259
|
205
|
569
|
1 952
|
606
|
|
| Other Current Assets |
279
|
257
|
446
|
614
|
135
|
1 618
|
1 652
|
2 386
|
2 268
|
|
| Total Current Assets |
5 695
|
9 437
|
161 091
|
134 657
|
71 920
|
45 472
|
80 535
|
75 539
|
144 151
|
|
| PP&E Net |
1 483
|
1 924
|
2 699
|
5 042
|
4 065
|
3 304
|
6 713
|
76 035
|
85 406
|
|
| PP&E Gross |
1 483
|
1 924
|
2 699
|
5 042
|
4 065
|
3 304
|
6 713
|
76 035
|
85 406
|
|
| Accumulated Depreciation |
155
|
521
|
1 072
|
2 513
|
4 426
|
6 251
|
6 230
|
8 169
|
8 219
|
|
| Intangible Assets |
270
|
369
|
507
|
2 753
|
2 708
|
2 556
|
2 610
|
2 534
|
2 390
|
|
| Long-Term Investments |
0
|
8 512
|
4 371
|
0
|
20 620
|
13 503
|
93 634
|
2 743
|
0
|
|
| Other Long-Term Assets |
83
|
128
|
200
|
450
|
582
|
617
|
1 689
|
3 294
|
28
|
|
| Total Assets |
7 530
N/A
|
20 370
+171%
|
168 869
+729%
|
142 903
-15%
|
99 894
-30%
|
65 453
-34%
|
185 181
+183%
|
160 144
-14%
|
231 976
+45%
|
|
| Liabilities | ||||||||||
| Accrued Liabilities |
11
|
7
|
13
|
30
|
98
|
16
|
184
|
165
|
398
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
801
|
940
|
502
|
1 167
|
784
|
43 637
|
|
| Other Current Liabilities |
292
|
1 337
|
11 573
|
8 496
|
6 930
|
8 232
|
70 821
|
40 810
|
19 326
|
|
| Total Current Liabilities |
303
|
1 344
|
11 586
|
9 327
|
7 969
|
8 750
|
72 172
|
41 760
|
63 361
|
|
| Long-Term Debt |
2 327
|
7 628
|
0
|
1 079
|
555
|
72
|
40 669
|
43 154
|
26
|
|
| Other Liabilities |
16 999
|
97 353
|
321
|
488
|
706
|
677
|
2 826
|
1 152
|
1 309
|
|
| Total Liabilities |
19 629
N/A
|
106 325
+442%
|
11 907
-89%
|
10 895
-8%
|
9 230
-15%
|
9 500
+3%
|
115 667
+1 118%
|
86 065
-26%
|
64 696
-25%
|
|
| Equity | ||||||||||
| Common Stock |
96
|
96
|
22 294
|
22 652
|
23 123
|
23 562
|
23 894
|
23 946
|
27 030
|
|
| Retained Earnings |
13 685
|
88 489
|
205 693
|
243 285
|
299 059
|
342 535
|
339 134
|
342 345
|
398 304
|
|
| Additional Paid In Capital |
1 489
|
2 437
|
332 918
|
334 393
|
342 465
|
348 732
|
361 173
|
363 760
|
510 998
|
|
| Other Equity |
0
|
0
|
7 443
|
18 248
|
24 136
|
26 194
|
23 580
|
28 718
|
27 556
|
|
| Total Equity |
12 099
N/A
|
85 955
-610%
|
156 962
N/A
|
132 008
-16%
|
90 665
-31%
|
55 953
-38%
|
69 513
+24%
|
74 079
+7%
|
167 280
+126%
|
|
| Total Liabilities & Equity |
7 530
N/A
|
20 370
+171%
|
168 869
+729%
|
142 903
-15%
|
99 894
-30%
|
65 453
-34%
|
185 181
+183%
|
160 144
-14%
|
231 976
+45%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
19
|
19
|
45
|
45
|
46
|
47
|
48
|
48
|
48
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
|
Switch to:
Switch to:
See Also
Discover More
